Icon Bioscience's Acquisition

Icon Bioscience was acquired by EyePoint Pharmaceuticals on March 28, 2018.

Icon Bioscience (IBI) is a privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary drug delivery platform, Verisome. IBI's…

Articles about Icon Bioscience's Acquisition: